Original ArticleABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab
Under a Creative Commons license
open archive
clinical research / practice
liver transplantation / hepatology
immunosuppression / immune modulation
ABO incompatibility
liver transplantation: living donor
B cell biology
desensitization
Abbreviations
ABOc
ABO compatible
ABOi
ABO incompatible
ACLF
acute-on-chronic liver failure
ACR
acute cellular rejection
ALC
alcoholic liver cirrhosis
ALDLT
adult living donor liver transplantation
AMR
antibody-mediated rejection
BMI
body mass index
BPACR
biopsy-proven acute cellular rejection
BS
biliary stricture
BTZ
bortezomib
CD20+
CD20-positive B lymphocyte
COD
cause of death
COGF
cause of graft failure
CMV
cytomegalovirus
CR
chronic rejection
Cx
complication
D
donor
DDLT
deceased donor liver transplantation
DIHBS
diffuse intrahepatic biliary stricture
DSZ
desensitization
F
female
FHF
fulminant hepatic failure
GSR
graft survival rate
GRWR
graft-to-recipient weight ratio
HA
hepatic artery
HAS
hepatic artery stenosis
HBV
hepatitis B virus
HCC
hepatocellular carcinoma
HCV
hepatitis C virus
HVS
hepatic vein stenosis
IA
isoagglutinin
ICU
intensive care unit
LDLT
living donor liver transplantation
LFT
liver function test
LGIT
local graft infusion therapy
LL
left lobe
LT
liver transplantation
M
male
MELD
Model for End-Stage Liver Disease
MMF
mycophenolate mofetil
MRL
modified right lobe
PCLD
polycystic liver disease
Pn
pneumonia
PSR
patient survival rate
PV
portal vein
PVS
portal vein stenosis
R
recipient
RBC
red blood cell
RIT
rituximab
RL
right lobe
SBC
secondary biliary cirrhosis
SFSG
small-for-size graft
SPL
splenectomy
T/F
transfusion
TPE
total plasma exchange
yr
year
Cited by (0)
Copyright © 2016 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.